Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Giovanni Di Napoli
Andrea Cherubini
Dominika Spilarova
Egle Gedrimaite
Federico Sommariva
Luigi Longo
Nhan Ngo Dingh
Silvia Miliani
Svetlana Sigalova
Board:
Alessandro Chà
Maria Grazia Roncarolo
John O'Dea
Mauro Ajani
Niall Donnelly
Silvana Perretta
Shareholding in %:
BlackRock Fund Advisors 0.72
Capital Research & Management Co. (World Investors) 4.03
Cosmo NV 2.99
Dimensional Fund Advisors LP 0.57
Gerald Herz 8
Mauro Severino Ajani 35.04
UBS Asset Management Switzerland AG 2.98
Vanguard Capital Management LLC 1.47
Zürcher Kantonalbank (Investment Management) 1.2
dievini Hopp BioTech holding GmbH & Co. KG 3.8
Freefloat 39.22
Address: Riverside II, Sir John Rogerson's Quay, 2 Dublin
T: +353-1-8170370
F: +353-1-8230718
I: http://www.cosmopharma.com
E: